Advertisement

Neurogenic Bladder in Cerebral Palsy: Upper Motor Neuron

  • Hong Truong
  • Ahmad H. Bani Hani
Living reference work entry

Abstract

Although most children with cerebral palsy can eventually develop total urinary control, more than 50% of them suffer from a spectrum of lower urinary tract symptoms. The severity of urinary symptoms depends on the extent of motor, mental, cognitive, and neurological disabilities associated with cerebral palsy. While routine urological evaluation in children with cerebral palsy is not indicated as in the case in children with spinal dysraphism, physicians who care for children with cerebral palsy should be familiar with urological manifestations of the disorder and refer children with voiding complaints for urological work up. Common lower urinary tract complaints in children with cerebral palsy include delay in toilet training, urinary incontinence, urinary frequency, urgency, hesitancy in voiding, incomplete emptying, and recurrent urinary tract infections. Urodynamic studies in select cerebral palsy patient populations demonstrate detrusor overactivity, reduced bladder capacity, detrusor-sphincter dyssynergy, and rarely impaired bladder compliance and upper urinary tract deterioration. In this chapter, we discuss the physiology of bladder function, urological presentations, diagnostic work up, and management of children with cerebral palsy.

Keywords

Neurogenic bladder Detrusor Urodynamic Uroflow Voiding diary Vesicoureteral reflux Chronic kidney disease Hydronephrosis Botulinum toxin 

References

  1. Allen HA et al (2007) Initial trial of timed voiding is warranted for all children with daytime incontinence. Urology 69(5):962–965PubMedCrossRefGoogle Scholar
  2. Appell RA et al (2001) Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT study. Mayo Clin Proc 76(4):358–363PubMedCrossRefGoogle Scholar
  3. Blackburn SC et al (2013) Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children. Journal of Pediatric Urology 9(6 Pt A):750–753PubMedCrossRefGoogle Scholar
  4. Blais A-S et al (2016) Prospective pilot study of Mirabegron in pediatric patients with overactive bladder. Eur Urol 70(1):9–13PubMedCrossRefGoogle Scholar
  5. Bolduc S et al (2010) Prospective open label study of solifenacin for overactive bladder in children. J Urol 184(4 Suppl):1668–1673PubMedCrossRefGoogle Scholar
  6. Brodak PP et al (1994) Is urinary tract screening necessary for patients with cerebral palsy? J Urol 152(5 Pt 1):1586–1587PubMedCrossRefGoogle Scholar
  7. Bross S et al (2007) Correlation between motor function and lower urinary tract dysfunction in patients with infantile cerebral palsy. Neurourol Urodyn 26(2):222–227PubMedCrossRefGoogle Scholar
  8. Cartwright PC et al (2009) Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity. J Urol 182(4):1548–1554PubMedCrossRefGoogle Scholar
  9. Cotter KJ et al (2016) Urodynamic findings in adults with moderate to severe cerebral palsy. Urology 95:216–221PubMedCrossRefGoogle Scholar
  10. Decter RM et al (1987) Urodynamic assessment of children with cerebral palsy. J Urol 138(4 Pt 2):1110–1112PubMedCrossRefGoogle Scholar
  11. Drigo P et al (1988) Neurogenic vesico-urethral dysfunction in children with cerebral palsy. Ital J Neurol Sci 9(2):151–154PubMedCrossRefGoogle Scholar
  12. Dwyer ME et al (2014) Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children. Urology 84(4):911–917PubMedCrossRefGoogle Scholar
  13. Ersöz M et al (2009) Noninvasive evaluation of lower urinary tract function in children with cerebral palsy. Am J Phys Med Rehabil 88(9):735–741PubMedCrossRefGoogle Scholar
  14. Fairhurst JJ et al (1991) Bladder capacity in infants. J Pediatr Surg 26(1):55–57PubMedCrossRefGoogle Scholar
  15. Goldfarb RA et al (2016) Neurogenic lower urinary tract dysfunction in adults with cerebral palsy: outcomes following a conservative management approach. J Urol 195(4 Pt 1):1009–1013PubMedCrossRefGoogle Scholar
  16. Groen L-A et al (2012) Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol 188(4):1313–1317PubMedCrossRefGoogle Scholar
  17. Gündoğdu G et al (2013) Relationship of bladder dysfunction with upper urinary tract deterioration in cerebral palsy. J Pediatr Urol 9(5):659–664PubMedCrossRefGoogle Scholar
  18. Hoebeke P et al (2006) The effect of botulinum-a toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176(1):328–330, discussion 330–331PubMedCrossRefGoogle Scholar
  19. Hunter KF, Bharmal A, Moore KN (2013) Long-term bladder drainage: suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn 32(7):944–951PubMedCrossRefGoogle Scholar
  20. Jansson U-B et al (2005) Voiding pattern and acquisition of bladder control from birth to age 6 years--a longitudinal study. J Urol 174(1):289–293PubMedCrossRefGoogle Scholar
  21. Karaman MI et al (2005) Urodynamic findings in children with cerebral palsy. Int J Urol 12(8):717–720PubMedCrossRefGoogle Scholar
  22. Kilicarslan H et al (2006) Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol 38(3–4):537–541PubMedGoogle Scholar
  23. Kinlaw AC et al (2017) Trends in pharmacotherapy for bladder dysfunction among children in the United States, 2000 to 2013. Clin Pediatr 56(1):55–64CrossRefGoogle Scholar
  24. Koff SA (1983) Estimating bladder capacity in children. Urology 21(3):248CrossRefGoogle Scholar
  25. Krach LE (2001) Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol 16(1):31–36PubMedCrossRefGoogle Scholar
  26. Largo RH, Stutzle W (1977) Longitudinal study of bowel and bladder control by day and at night in the first six years of life. I: epidemiology and interrelations between bowel and bladder control. Dev Med Child Neurol 19(5):598–606PubMedCrossRefGoogle Scholar
  27. Leyson JF, Martin BF, Sporer A (1980) Baclofen in the treatment of detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 124(1):82–84PubMedCrossRefGoogle Scholar
  28. Lopez Pereira P et al (2003) Trospium chloride for the treatment of detrusor instability in children. J Urol 170(5):1978–1981PubMedCrossRefGoogle Scholar
  29. MacLellan DL, Bauer SB (2016) Neuromuscular dysfunction of the lower urinary tract in children. In: Wein AJ et al (eds) Campbell-Walsh Urology. Elsevier, Philadelphia, pp 3272–3296Google Scholar
  30. Malhotra B et al (2012) Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder. J Pediatr Urol 8(4):336–342PubMedCrossRefGoogle Scholar
  31. Marciniak C et al (2014) Urinary incontinence in adults with cerebral palsy: prevalence, type, and effects on participation. PM & R 6(2):110–120, quiz 120CrossRefGoogle Scholar
  32. Marte A et al (2010) Effectiveness of botulinum-a toxin for the treatment of refractory overactive bladder in children. Eur J Pediatric Surg/Zeitschrift fur Kinderchirurgie 20(3):153–157Google Scholar
  33. Mayo ME (1992) Lower urinary tract dysfunction in cerebral palsy. J Urol 147(2):419–420PubMedCrossRefGoogle Scholar
  34. McKenna PH et al (1999) Pelvic floor muscle retraining for pediatric voiding dysfunction using interactive computer games. Journal Urol 162(3 Pt 2):1056–1062, discussion 1062–3CrossRefGoogle Scholar
  35. Morin F et al (2017) Dual therapy for refractory overactive bladder in children: a prospective open-label study. J Urol 197(4):1158–1163PubMedCrossRefGoogle Scholar
  36. Murphy KP, Boutin SA, Ide KR (2012) Cerebral palsy, neurogenic bladder, and outcomes of lifetime care. Dev Med Child Neurol 54(10):945–950PubMedCrossRefGoogle Scholar
  37. Palmer LS (2016) Evaluation and targeted therapy of voiding dysfunction in children. Urology 92:87–94PubMedCrossRefGoogle Scholar
  38. Pan D et al (2009) Long-term outcomes of external sphincterotomy in a spinal injured population. J Urol 181(2):705–709PubMedCrossRefGoogle Scholar
  39. Reid CJ, Borzyskowski M (1993) Lower urinary tract dysfunction in cerebral palsy. Arch Dis Child 68(6):739–742PubMedPubMedCentralCrossRefGoogle Scholar
  40. Reinberg Y et al (2003) Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. J Urol 169(1):317–319PubMedCrossRefGoogle Scholar
  41. Richardson I, Palmer LS (2009) Clinical and urodynamic spectrum of bladder function in cerebral palsy. J Urol 182(4 Suppl):1945–1948PubMedCrossRefGoogle Scholar
  42. Roberts KB (2012) Revised AAP guideline on UTI in febrile infants and young children. Am Fam Physician 86(10):940–946PubMedGoogle Scholar
  43. Roijen LE et al (2001) Development of bladder control in children and adolescents with cerebral palsy. Dev Med Child Neurol 43(2):103–107PubMedCrossRefGoogle Scholar
  44. Samijn B et al (2017) Lower urinary tract symptoms and urodynamic findings in children and adults with cerebral palsy: a systematic review. Neurourol Urodyn 36(3):541–549PubMedCrossRefGoogle Scholar
  45. Schurch B et al (1996) Botulinum-a toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 155(3):1023–1029PubMedCrossRefGoogle Scholar
  46. Silva JAF et al (2010) Lower urinary tract dysfunction and ultrasound assessment of bladder wall thickness in children with cerebral palsy. Urology 76(4):942–945PubMedCrossRefGoogle Scholar
  47. Silva JAF et al (2009) Lower urinary tract dysfunction in children with cerebral palsy. Neurourol Urodyn 28(8):959–963PubMedCrossRefGoogle Scholar
  48. Thom M et al (2012) Management of lower urinary tract dysfunction: a stepwise approach. J Pediatr Urol 8(1):20–24PubMedCrossRefGoogle Scholar
  49. Vainrib M, Reyblat P, Ginsberg DA (2014) Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury. Urology 84(4):940–945PubMedCrossRefGoogle Scholar
  50. Vricella GJ et al (2014) Long-term efficacy and durability of botulinum-a toxin for refractory dysfunctional voiding in children. J Urol 191(5 Suppl):1586–1591PubMedCrossRefGoogle Scholar
  51. Youdim K, Kogan BA (2002) Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology 59(3):428–432PubMedCrossRefGoogle Scholar
  52. Young NL et al (2011) Reasons for hospital admissions among youth and young adults with cerebral palsy. Arch Phys Med Rehabil 92(1):46–50PubMedCrossRefGoogle Scholar
  53. Yıldız N et al (2017) Cross-sectional study of urinary problems in adults with cerebral palsy: awareness and impact on the quality of life. Neurolo Sci 38(7):1193–1203CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of UrologyThomas Jefferson University HospitalPhiladelphiaUSA
  2. 2.Division of Pediatric UrologyNemours/Alfred I. duPont Hospital for ChildrenWilmingtonUSA
  3. 3.Department of Urology and PediatricsSidney Kimmel Medical college-Thomas Jefferson UniversityPhiladelphiaUSA

Section editors and affiliations

  • Freeman Miller
    • 1
  • Steven J. Bachrach
    • 2
    • 3
  1. 1.Nemours Alfred I. duPont Hospital for ChildrenWilmingtonUSA
  2. 2.Department of Pediatrics (Emeritus)Nemours/Alfred I. duPont Hospital for ChildrenWilmingtonUSA
  3. 3.Sidney Kimmel Medical College of Thomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations